Early-Stage HIV drug trial halted after testing in small group
NCT ID NCT06061081
Summary
This study tested a new drug called VH3739937 to see if it could lower the amount of HIV virus in people who had never taken HIV medication before. It involved 21 participants and compared the drug against a placebo (a dummy pill) for a short period. The main goal was to measure how much the virus decreased and to check the drug's safety, but the trial was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Brescia, 25123, Italy
-
GSK Investigational Site
Genova, 16132, Italy
-
GSK Investigational Site
Milan, 20142, Italy
-
GSK Investigational Site
Roma, 00133, Italy
-
GSK Investigational Site
Warsaw, 01-201, Poland
-
GSK Investigational Site
A Coruña, 15006, Spain
-
GSK Investigational Site
Alicante, 03010, Spain
-
GSK Investigational Site
Granada, 18014, Spain
-
GSK Investigational Site
Jerez de la Frontera, 11407, Spain
-
GSK Investigational Site
Madrid, 28006, Spain
-
GSK Investigational Site
Madrid, 28222, Spain
-
GSK Investigational Site
Vitoria-Gasteiz, 1009, Spain
-
GSK Investigational Site
Bakersfield, California, 93301, United States
-
GSK Investigational Site
Miami, Florida, 33136, United States
-
GSK Investigational Site
Dallas, Texas, 75246, United States
-
GSK Investigational Site
Buenos Aires, C1181ACH, Argentina
-
GSK Investigational Site
Rosario, 2000, Argentina
-
GSK Investigational Site
Athens, 12462, Greece
Conditions
Explore the condition pages connected to this study.